TY - JOUR AU - Michonneau, D. AU - Suarez, F. AU - Lambert, J. PY - 2013 DA - 2013// TI - Late-onset post-transplantation lymphoproliferative disorders after kidney transplantation: a monocentric study over three decades JO - Nephrol Dial Transplant VL - 28 UR - https://doi.org/10.1093/ndt/gfs476 DO - 10.1093/ndt/gfs476 ID - Michonneau2013 ER - TY - JOUR AU - Starzl, T. E. AU - Nalesnik, M. A. AU - Porter, K. A. PY - 1984 DA - 1984// TI - Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy JO - Lancet VL - 1 UR - https://doi.org/10.1016/S0140-6736(84)90994-2 DO - 10.1016/S0140-6736(84)90994-2 ID - Starzl1984 ER - TY - JOUR AU - Campo, E. AU - Swerdlow, S. H. AU - Harris, N. L. PY - 2011 DA - 2011// TI - The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2011-01-293050 DO - 10.1182/blood-2011-01-293050 ID - Campo2011 ER - TY - JOUR AU - Petrara, M. R. AU - Giunco, S. AU - Serraino, D. PY - 2015 DA - 2015// TI - Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment JO - Cancer Lett VL - 369 UR - https://doi.org/10.1016/j.canlet.2015.08.007 DO - 10.1016/j.canlet.2015.08.007 ID - Petrara2015 ER - TY - JOUR AU - Opelz, G. AU - Henderson, R. PY - 1993 DA - 1993// TI - Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients JO - Lancet VL - 342 UR - https://doi.org/10.1016/S0140-6736(05)80084-4 DO - 10.1016/S0140-6736(05)80084-4 ID - Opelz1993 ER - TY - JOUR AU - Cockfield, S. M. PY - 2001 DA - 2001// TI - Identifying the patient at risk for post-transplant lymphoproliferative disorder JO - Transpl Infect Dis VL - 3 UR - https://doi.org/10.1034/j.1399-3062.2001.003002070.x DO - 10.1034/j.1399-3062.2001.003002070.x ID - Cockfield2001 ER - TY - JOUR AU - Opelz, G. AU - Döhler, B. PY - 2004 DA - 2004// TI - Lymphomas after solid organ transplantation: a collaborative transplant study report JO - Am J Transplant VL - 4 UR - https://doi.org/10.1046/j.1600-6143.2003.00325.x DO - 10.1046/j.1600-6143.2003.00325.x ID - Opelz2004 ER - TY - JOUR AU - Wistinghausen, B. AU - Gross, T. G. AU - Bollard, C. PY - 2013 DA - 2013// TI - Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipients JO - Pediatr Hematol Oncol VL - 30 UR - https://doi.org/10.3109/08880018.2013.798844 DO - 10.3109/08880018.2013.798844 ID - Wistinghausen2013 ER - TY - JOUR AU - Uhlin, M. AU - Wikell, H. AU - Sundin, M. PY - 2014 DA - 2014// TI - Risk factors for epstein-barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation JO - Haematologica VL - 99 UR - https://doi.org/10.3324/haematol.2013.087338 DO - 10.3324/haematol.2013.087338 ID - Uhlin2014 ER - TY - JOUR AU - Nakanishi, C. AU - Kawagishi, N. AU - Sekiguchi, S. PY - 2012 DA - 2012// TI - Post-transplantation lymphoproliferative disorder in living-donor liver transplantation: a single-center experience JO - Surg Today VL - 42 UR - https://doi.org/10.1007/s00595-012-0127-7 DO - 10.1007/s00595-012-0127-7 ID - Nakanishi2012 ER - TY - JOUR AU - Styczynski, J. AU - Gil, L. AU - Tridello, G. PY - 2013 DA - 2013// TI - Response to rituximab-based therapy and risk factor analysis in epstein barr virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the infectious diseases working party of the European Group for blood and marrow transplantation JO - Clin Infect Dis VL - 57 UR - https://doi.org/10.1093/cid/cit391 DO - 10.1093/cid/cit391 ID - Styczynski2013 ER - TY - JOUR AU - Swerdlow, S. H. AU - Campo, E. AU - Pileri, S. A. PY - 2016 DA - 2016// TI - The 2016 revision of the World Health Organization classification of lymphoid neoplasms JO - Blood VL - 127 UR - https://doi.org/10.1182/blood-2016-01-643569 DO - 10.1182/blood-2016-01-643569 ID - Swerdlow2016 ER - TY - JOUR AU - Parker, A. AU - Bowles, K. AU - Bradley, J. A. PY - 2010 DA - 2010// TI - Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients—BCSH and BTS guidelines JO - Br J Haematol VL - 149 UR - https://doi.org/10.1111/j.1365-2141.2010.08160.x DO - 10.1111/j.1365-2141.2010.08160.x ID - Parker2010 ER - TY - JOUR AU - Tsai, D. E. AU - Hardy, C. L. AU - Tomaszewski, J. E. PY - 2001 DA - 2001// TI - Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients JO - Transplantation VL - 71 UR - https://doi.org/10.1097/00007890-200104270-00012 DO - 10.1097/00007890-200104270-00012 ID - Tsai2001 ER - TY - JOUR AU - Ghobrial, I. M. AU - Habermann, T. M. AU - Ristow, K. M. PY - 2005 DA - 2005// TI - Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era JO - Leuk Lymphoma VL - 46 UR - https://doi.org/10.1080/10428190400012011 DO - 10.1080/10428190400012011 ID - Ghobrial2005 ER - TY - JOUR AU - Choquet, S. AU - Leblond, V. AU - Herbrecht, R. PY - 2006 DA - 2006// TI - Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study JO - Blood. VL - 107 UR - https://doi.org/10.1182/blood-2005-01-0377 DO - 10.1182/blood-2005-01-0377 ID - Choquet2006 ER - TY - STD TI - Trappe RU, Dierickx D, Zimmermann H, et al. Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-chop consolidation in an international, prospective, multicenter phase II trial. J Clin Oncol 2016;JCO2016693564. ID - ref17 ER - TY - JOUR AU - Dharnidharka, V. R. AU - Webster, A. C. AU - Martinez, O. M. PY - 2016 DA - 2016// TI - Post-transplant lymphoproliferative disorders JO - Nat Rev Dis Primers. VL - 2 UR - https://doi.org/10.1038/nrdp.2015.88 DO - 10.1038/nrdp.2015.88 ID - Dharnidharka2016 ER - TY - JOUR AU - Choquet, S. AU - Trappe, R. AU - Leblond, V. PY - 2007 DA - 2007// TI - CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation JO - Haematologica VL - 92 UR - https://doi.org/10.3324/haematol.10595 DO - 10.3324/haematol.10595 ID - Choquet2007 ER - TY - STD TI - Trappe R, Oertel S, Leblond V, et al. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol. 2012;13:196–206. ID - ref20 ER - TY - JOUR AU - Mynarek, M. AU - Schober, T. AU - Behrends, U. PY - 2013 DA - 2013// TI - Posttransplant lymphoproliferative disease after pediatric solid organ transplantation JO - J Immunol Res VL - 2013 ID - Mynarek2013 ER - TY - JOUR AU - Gross, T. G. AU - Orjuela, M. A. AU - Perkins, S. L. PY - 2012 DA - 2012// TI - Low-dose chemotherapy and rituximab for post-transplant lymphoproliferative disease (PTLD): a Children’s Oncology Group report JO - Am J Transplant VL - 12 UR - https://doi.org/10.1111/j.1600-6143.2012.04206.x DO - 10.1111/j.1600-6143.2012.04206.x ID - Gross2012 ER - TY - JOUR AU - Leblond, V. AU - Dhedin, N. AU - Mamzer Bruneel, M. F. PY - 2001 DA - 2001// TI - Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders JO - J Clin Oncol VL - 19 UR - https://doi.org/10.1200/JCO.2001.19.3.772 DO - 10.1200/JCO.2001.19.3.772 ID - Leblond2001 ER - TY - JOUR AU - Jain, A. AU - Nalesnik, M. AU - Reyes, J. PY - 2002 DA - 2002// TI - Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience JO - Ann Surg VL - 236 UR - https://doi.org/10.1097/00000658-200210000-00005 DO - 10.1097/00000658-200210000-00005 ID - Jain2002 ER - TY - JOUR AU - Ghobrial, I. M. AU - Habermann, T. M. AU - Maurer, M. J. PY - 2005 DA - 2005// TI - Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.01.0934 DO - 10.1200/JCO.2005.01.0934 ID - Ghobrial2005 ER - TY - JOUR AU - Maecker, B. AU - Jack, T. AU - Zimmermann, M. PY - 2007 DA - 2007// TI - CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.10.2392 DO - 10.1200/JCO.2006.10.2392 ID - Maecker2007 ER - TY - JOUR AU - Oton, A. B. AU - Wang, H. AU - Leleu, X. PY - 2008 DA - 2008// TI - Clinical and pathological prognostic markers for survival in adult patients with post-transplant lymphoproliferative disorders in solid transplant JO - Leuk Lymphoma VL - 49 UR - https://doi.org/10.1080/10428190802239162 DO - 10.1080/10428190802239162 ID - Oton2008 ER - TY - JOUR AU - Knight, J. S. AU - Tsodikov, A. AU - Cibrik, D. M. PY - 2009 DA - 2009// TI - Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.20.0857 DO - 10.1200/JCO.2008.20.0857 ID - Knight2009 ER - TY - JOUR AU - Evens, A. M. AU - David, K. A. AU - Helenowski, I. PY - 2010 DA - 2010// TI - Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.25.4961 DO - 10.1200/JCO.2009.25.4961 ID - Evens2010 ER - TY - JOUR AU - Kinch, A. AU - Baecklund, E. AU - Backlin, C. PY - 2014 DA - 2014// TI - A population-based study of 135 lymphomas after solid organ transplantation: the role of epstein-barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival JO - Acta Oncol VL - 53 UR - https://doi.org/10.3109/0284186X.2013.844853 DO - 10.3109/0284186X.2013.844853 ID - Kinch2014 ER - TY - JOUR AU - Dierickx, D. AU - Tousseyn, T. AU - Sagaert, X. PY - 2013 DA - 2013// TI - Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors JO - Leuk Lymphoma VL - 54 UR - https://doi.org/10.3109/10428194.2013.780655 DO - 10.3109/10428194.2013.780655 ID - Dierickx2013 ER - TY - JOUR AU - Montanari, F. AU - Radeski, D. AU - Seshan, V. PY - 2015 DA - 2015// TI - Recursive partitioning analysis of prognostic factors in post-transplant lymphoproliferative disorders (PTLD): a 120 case single institution series JO - Br J Haematol VL - 171 UR - https://doi.org/10.1111/bjh.13621 DO - 10.1111/bjh.13621 ID - Montanari2015 ER - TY - JOUR AU - Luskin, M. R. AU - Heil, D. S. AU - Tan, K. S. PY - 2015 DA - 2015// TI - The impact of EBV status on characteristics and outcomes of posttransplantation lymphoproliferative disorder JO - Am J Transplant VL - 15 UR - https://doi.org/10.1111/ajt.13324 DO - 10.1111/ajt.13324 ID - Luskin2015 ER - TY - JOUR AU - Caillard, S. AU - Dharnidharka, V. AU - Agodoa, L. PY - 2005 DA - 2005// TI - Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression JO - Transplantation VL - 80 UR - https://doi.org/10.1097/01.tp.0000179639.98338.39 DO - 10.1097/01.tp.0000179639.98338.39 ID - Caillard2005 ER - TY - JOUR AU - Kremers, W. K. AU - Devarbhavi, H. C. AU - Wiesner, R. H. PY - 2006 DA - 2006// TI - Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival JO - Am J Transplant VL - 6 UR - https://doi.org/10.1111/j.1600-6143.2006.01294.x DO - 10.1111/j.1600-6143.2006.01294.x ID - Kremers2006 ER - TY - JOUR AU - Gao, S. Z. AU - Chaparro, S. V. AU - Perlroth, M. PY - 2003 DA - 2003// TI - Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University JO - J Heart Lung Transplant VL - 22 UR - https://doi.org/10.1016/S1053-2498(02)01229-9 DO - 10.1016/S1053-2498(02)01229-9 ID - Gao2003 ER -